California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993

The California Drug and Alcohol Treatment Assessment (CALDATA) was designed to study the costs, benefits, and effectiveness of the state's alcohol and drug treatment infrastructure (recovery services) and specifically to assess (1) the effects of treatment on participant behavior, (2) the costs...

Descripción completa

Guardado en:  
Detalles Bibliográficos
Autor Corporativo: California Department of Alcohol and Drug Programs. VerfasserIn (Autor)
Tipo de documento: Electrónico Research Data
Lenguaje:Inglés
Publicado: [Erscheinungsort nicht ermittelbar] [Verlag nicht ermittelbar] 2004
En:Año: 2004
Acceso en línea: Volltext (kostenfrei)
Verificar disponibilidad: HBZ Gateway
Palabras clave:

MARC

LEADER 00000cam a22000002c 4500
001 190279074X
003 DE-627
005 20250623094030.0
007 cr uuu---uuuuu
008 240918s2004 xx |||||o 00| ||eng c
024 7 |a 10.3886/ICPSR02295.v1  |2 doi 
035 |a (DE-627)190279074X 
035 |a (DE-599)KXP190279074X 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 2,1  |2 ssgn 
110 2 |a California Department of Alcohol and Drug Programs  |e VerfasserIn  |4 aut 
245 1 0 |a California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993 
264 1 |a [Erscheinungsort nicht ermittelbar]  |b [Verlag nicht ermittelbar]  |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The California Drug and Alcohol Treatment Assessment (CALDATA) was designed to study the costs, benefits, and effectiveness of the state's alcohol and drug treatment infrastructure (recovery services) and specifically to assess (1) the effects of treatment on participant behavior, (2) the costs of treatment, and (3) the economic value of treatment to society. Data were collected on participants (clients) across four types of treatment programs, or modalities: residential, residential "social model," nonmethadone outpatient, and outpatient methadone (detoxification and maintenance). Data were collected in two phases. In Phase 1, treatment records were abstracted for clients who received treatment or were discharged between October 1, 1991, and September 30, 1992. In Phase 2, these clients were located and recruited for a follow-up interview. The CALDATA design and procedures included elements from several national treatment outcome studies including the Drug Services Research Survey (ICPSR 3393), Services Research Outcomes Study (ICPSR 2691), National Treatment Improvement Evaluation Study (ICPSR 2884), and Drug Abuse Treatment Outcome Study (ICPSR 2258). The record abstract was designed to collect identifying and locating information for interview reference during the personal interviewing phase. The abstract also collected demographic, drug, or alcohol use, and treatment and service information. The follow-up questionnaire covered time periods before, during, and after treatment and focused on topics such as ethnic and educational background, drug and alcohol use, mental and physical health, HIV and AIDS status, drug testing, illegal activities and criminal status, living arrangements and family issues, employment and income, and treatment for drug, alcohol, and mental health problems. Drugs included alcohol, barbiturates, benzodiazepines, cocaine powder, crack, downers, hallucinogens, heroin, illegal methadone, inhalants, LSD, marijuana/hashish/THC, methamphetamines and other stimulants, narcotics, over-the-counter drugs, PCP, ritalin or preludin, and sedatives/hypnotics. CALDATA was originally known as the California Outcomes Study (COS). 
540 |a ICPSR Terms of Use 
650 4 |a Alcohol 
650 4 |a Cocaine 
650 4 |a COST effectiveness 
650 4 |a Drug treatment 
650 4 |a Drugs 
650 4 |a Employment 
650 4 |a Hallucinogens 
650 4 |a Heroin 
650 4 |a illegal activities 
650 4 |a inhalants 
650 4 |a Intervention 
650 4 |a Marijuana 
650 4 |a Mental Health 
650 4 |a methadone 
650 4 |a methadone maintenance 
650 4 |a methamphetamines 
650 4 |a Physical Health 
650 4 |a Program Evaluation 
650 4 |a Substance Abuse 
650 4 |a Substance Abuse Treatment 
650 4 |a treatment costs 
650 4 |a treatment programs 
655 7 |a Forschungsdaten  |0 (DE-588)1098579690  |0 (DE-627)857755366  |0 (DE-576)469182156  |2 gnd-content 
787 0 8 |i Forschungsdaten zu  |a Oreski, Dijana  |t Effects of dataset characteristics on the performance of feature selection techniques  |d 2017  |w (DE-627)1912530899 
856 4 0 |u https://doi.org/10.3886/ICPSR02295.v1  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
935 |a mkri 
951 |a BO 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4581182182 
LOK |0 003 DE-627 
LOK |0 004 190279074X 
LOK |0 005 20240918043617 
LOK |0 008 240918||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-2619)ICPSR2295 
LOK |0 040   |a DE-2619  |c DE-627  |d DE-2619 
LOK |0 092   |o n 
LOK |0 852   |a DE-2619 
LOK |0 852 1  |9 00 
LOK |0 935   |a foda  |a nacj 
LOK |0 939   |a 18-09-24  |b l01 
OAS |a 1 
ORI |a SA-MARC-krimdoka001.raw